Your browser is no longer supported. Please, upgrade your browser.
Settings
TTOO [NASD]
T2 Biosystems, Inc.
Index- P/E- EPS (ttm)-0.30 Insider Own0.70% Shs Outstand148.23M Perf Week-3.74%
Market Cap156.10M Forward P/E- EPS next Y-0.30 Insider Trans-6.10% Shs Float143.07M Perf Month-13.45%
Income-42.50M PEG- EPS next Q-0.08 Inst Own18.00% Short Float5.77% Perf Quarter-25.36%
Sales22.50M P/S6.94 EPS this Y70.30% Inst Trans2.10% Short Ratio1.93 Perf Half Y-48.24%
Book/sh0.00 P/B- EPS next Y3.20% ROA-60.60% Target Price- Perf Year-36.81%
Cash/sh0.22 P/C4.69 EPS next 5Y- ROE-796.60% 52W Range1.00 - 3.79 Perf YTD-16.94%
Dividend- P/FCF- EPS past 5Y29.50% ROI-76.70% 52W High-72.82% Beta0.26
Dividend %- Quick Ratio3.90 Sales past 5Y45.20% Gross Margin0.60% 52W Low3.00% ATR0.05
Employees148 Current Ratio4.30 Sales Q/Q180.00% Oper. Margin- RSI (14)38.89 Volatility3.62% 5.20%
OptionableYes Debt/Eq- EPS Q/Q67.00% Profit Margin- Rel Volume0.52 Prev Close1.04
ShortableYes LT Debt/Eq- EarningsAug 05 AMC Payout- Avg Volume4.28M Price1.03
Recom1.70 SMA20-3.78% SMA50-12.77% SMA200-31.25% Volume2,228,092 Change-0.96%
Jan-27-21Downgrade Alliance Global Partners Buy → Neutral $2.60 → $2.40
Oct-08-20Initiated BTIG Research Buy $2.50
Nov-26-19Downgrade Janney Buy → Neutral
Aug-01-19Downgrade Alliance Global Partners Buy → Neutral
Jul-31-19Downgrade Janney Buy → Neutral
Jul-31-19Downgrade H.C. Wainwright Buy → Neutral
May-16-19Initiated Alliance Global Partners Buy $5
Mar-08-19Reiterated H.C. Wainwright Buy $14 → $11
Jun-01-18Upgrade Leerink Partners Mkt Perform → Outperform
May-30-18Reiterated H.C. Wainwright Buy $8.50 → $14
May-29-18Reiterated WBB Securities Strong Buy $12 → $20
Mar-29-18Reiterated H.C. Wainwright Buy $8 → $8.50
Jan-29-18Initiated Goldman Neutral $5.20
Oct-18-17Initiated H.C. Wainwright Buy $8
Mar-15-17Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-10-16Resumed Leerink Partners Mkt Perform $5
Nov-02-16Reiterated Cantor Fitzgerald Buy $10 → $9
Jul-20-16Upgrade WBB Securities Buy → Strong Buy $11 → $12
Jun-22-16Upgrade WBB Securities Speculative Buy → Buy $11
Apr-12-16Reiterated Canaccord Genuity Buy $13 → $12
Jul-29-21 03:05PM  
Jul-28-21 08:29AM  
Jul-22-21 04:05PM  
Jul-19-21 04:59PM  
Jun-21-21 08:00AM  
Jun-11-21 09:00AM  
May-25-21 04:46PM  
10:38AM  
May-19-21 06:23AM  
May-14-21 03:41PM  
May-06-21 08:35PM  
04:05PM  
04:04PM  
02:45PM  
Apr-27-21 08:00AM  
Apr-22-21 04:05PM  
Mar-30-21 08:00AM  
Mar-26-21 04:05PM  
Mar-15-21 04:11PM  
Mar-09-21 08:45AM  
Mar-04-21 06:25PM  
05:40PM  
04:26PM  
04:05PM  
02:30PM  
Feb-23-21 08:00AM  
Feb-08-21 04:07PM  
Feb-05-21 03:53PM  
10:35AM  
Feb-04-21 04:05PM  
Jan-29-21 04:05PM  
03:18AM  
Jan-27-21 07:35AM  
Jan-26-21 04:45PM  
Jan-12-21 02:06PM  
09:53AM  
08:15AM  
Jan-11-21 06:19PM  
Jan-07-21 08:00AM  
Dec-31-20 08:42AM  
Dec-30-20 10:28AM  
Nov-28-20 09:03PM  
Nov-12-20 04:32PM  
Nov-10-20 07:38AM  
Nov-09-20 11:23AM  
Nov-04-20 07:05PM  
05:26PM  
04:05PM  
Oct-28-20 03:30PM  
12:32PM  
Oct-19-20 04:42PM  
Oct-14-20 04:05PM  
Oct-08-20 11:30AM  
Sep-30-20 09:00AM  
Sep-22-20 11:30AM  
Sep-16-20 01:11PM  
08:00AM  
Sep-04-20 11:30AM  
07:00AM  
Sep-01-20 10:10AM  
01:27AM  
Aug-31-20 04:05PM  
Aug-26-20 01:08PM  
Aug-25-20 06:19AM  
Aug-24-20 11:12AM  
Aug-18-20 11:30AM  
08:55AM  
Aug-11-20 04:49PM  
04:05PM  
Aug-10-20 11:08AM  
Aug-05-20 07:30AM  
Jul-31-20 05:45PM  
Jul-30-20 04:05PM  
Jul-28-20 04:05PM  
11:13AM  
Jul-24-20 05:45PM  
Jul-07-20 05:50PM  
Jul-02-20 10:12AM  
Jul-01-20 08:12AM  
Jun-30-20 04:06PM  
04:04PM  
Jun-26-20 08:00AM  
Jun-24-20 11:30AM  
Jun-17-20 07:30AM  
Jun-15-20 04:06PM  
Jun-08-20 09:18AM  
Jun-05-20 11:30AM  
May-26-20 10:11AM  
08:58AM  
May-19-20 08:30AM  
May-17-20 12:22PM  
May-05-20 04:05PM  
Apr-30-20 07:56AM  
Apr-21-20 04:22PM  
Apr-15-20 05:06PM  
Mar-26-20 08:48AM  
Mar-25-20 07:29AM  
Mar-24-20 04:31PM  
04:30PM  
Mar-19-20 08:00AM  
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance technology that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida Panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood. In addition, it provides T2Bacteria Panel, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2SARS-CoV-2 Panel, a COVID-19 molecular diagnostic test; and T2Resistance Panel for the early and sensitive detection of carbapenemase-resistance markers. Further, it develops T2Cauris Panel, a multi-drug resistant pathogen; and T2Lyme Panel for the detection of various strains of Lyme disease-causing bacteria. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McDonough JohnDirectorJul 01Sale1.1618,18221,091516,386Jul 02 04:00 PM
Gibbs Michael TerrenceGeneral CounselMar 25Sale1.568,75813,66273,256Mar 25 03:17 PM
Pare AnthonyChief Commercial OfficerMar 17Sale1.849,62017,70131,612Mar 18 04:34 PM
Barclay AlecChief Operations OfficerMar 17Sale1.8612,49423,23974,420Mar 18 04:34 PM
Gibbs Michael TerrenceGeneral CounselFeb 23Sale2.067,28014,99765,347Feb 23 02:23 PM
Sprague John MChief Financial OfficerFeb 23Sale2.045,25010,71035,485Feb 23 02:19 PM
Barclay AlecChief Operations OfficerFeb 23Sale2.067,28014,99765,247Feb 23 02:14 PM